Summarized & reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 3, 2026
The marker your annual physical almost never orders Walk into a routine physical in the United States and ask for a "complete iron panel." Most primary care providers won't order one unless you're female, pregnant, or visibly anemic. A standard CBC measures hemoglobin and hematocrit — that tells you whether your red blood cells are carrying oxygen today. It does not tell you anything about how…
This dispatch covers Your Ferritin Is 300 and Your Doctor Says You're Fine — That's Not Normal, That's the Problem in the research research category, authored by The Peptide Dispatch Editorial Team. Estimated reading time: 9 minutes. The Peptide Dispatch curates peer-reviewed peptide research for self-directed learners. All summaries are presented for Research Use Only and do not constitute medical advice.
Walk into a routine physical in the United States and ask for a "complete iron panel." Most primary care providers won't order one unless you're female, pregnant, or visibly anemic. A standard CBC measures hemoglobin and hematocrit — that tells you whether your red blood cells are carrying oxygen today. It does not tell you anything about how much iron is sitting in storage inside your liver, your heart, your pancreas, and your endocrine tissue.
Ferritin does. And in men over 35, ferritin is one of the most underused predictive markers in the entire blood panel.
The conventional reference range for men is roughly 20 to 336 ng/mL, depending on the lab. The functional range — the range at which longevity research and metabolic studies suggest the body is operating without excess iron load or chronic inflammation — is much narrower: roughly 60 to 120 ng/mL in men.
That gap is where chronic disease quietly accumulates for years before any other marker on a basic metabolic panel ever moves.
Ferritin is a protein that stores iron inside cells. When the body absorbs more iron than it immediately needs, it packages the excess into ferritin and warehouses it primarily in liver tissue. A small fraction of that stored ferritin leaks into the bloodstream, and the serum ferritin concentration is what shows up on a lab report.
That's the iron-storage role. But ferritin has a second job that makes interpretation tricky: it is also an acute-phase reactant, meaning it rises in response to systemic inflammation.
When the immune system is activated — by infection, injury, metabolic stress, visceral adiposity, autoimmune flare, or chronic low-grade inflammation — the liver upregulates ferritin production as part of a defensive iron-sequestration response. Pathogens need iron to replicate. Hiding iron away in ferritin is a useful short-term defense.
The problem: when inflammation becomes chronic, that defensive response becomes chronic too. Ferritin stays elevated. And the elevation is no longer protective — it's a signal that something upstream is dysregulated and hasn't resolved.
This is why ferritin is one of the most informative single markers on a blood panel. A high ferritin in the absence of true iron overload almost always means inflammation. A high ferritin with iron overload means both — and that combination accelerates oxidative damage faster than either condition alone.
Lab reference ranges are statistical, not clinical. They describe the middle 95 percent of whoever showed up to get blood drawn — a population that includes a large fraction of people with undiagnosed insulin resistance, nonalcoholic fatty liver disease, and subclinical inflammation. When the reference population is metabolically unhealthy, the reference range becomes a description of disease, not health.
Several lines of evidence push the optimal ferritin range well below the upper limit most labs flag:
Translation: a ferritin of 280 ng/mL in a 48-year-old executive who is otherwise told he is "fine" is not fine. It is, with reasonable probability, the earliest blood-based fingerprint of metabolic dysfunction that will not show up on a fasting glucose or A1c for another five to ten years.
Premenopausal women lose roughly 30–40 mg of iron each menstrual cycle. Over a year, that is several hundred milligrams of iron removed from the body without effort. Men have no equivalent excretion pathway. The body can absorb iron, but it has no regulated mechanism to dump it.
This is why iron overload, hereditary hemochromatosis, and metabolic hyperferritinaemia are disproportionately problems of men and postmenopausal women. By age 40, a man eating a typical Western diet — fortified grains, red meat, supplemental multivitamins containing iron — can accumulate iron stores well above the level associated with optimal cardiovascular and metabolic outcomes, without any awareness it's happening.
The body's only meaningful iron-disposal mechanism is loss of blood. Historically, that meant injury or parasitic infection. In a modern adult with neither, iron only goes up.
A ferritin above the functional range — particularly above 200 ng/mL in a man without obvious infection or recent inflammatory event — clusters statistically with:
Statistical clustering does not prove causation. But the mechanistic picture is consistent: excess iron deposits in metabolically active tissue (liver, pancreas, heart, adipose), catalyzes oxidative stress through Fenton chemistry, accelerates lipid peroxidation, and impairs insulin signaling. In experimental models, reducing iron stores improves insulin sensitivity. In humans with metabolic syndrome and elevated ferritin, therapeutic phlebotomy has been associated with improvements in insulin resistance and hepatic enzymes in controlled studies.
That's the punch line: ferritin is not just a passive bystander reporting on metabolic state. The iron it represents is biologically active and contributes to the dysfunction it tracks.
Ferritin alone is not enough. To make sense of a number, the panel needs three additional markers:
With those four numbers, the picture resolves. Ferritin 320, TSAT 52 percent, hsCRP 0.8 mg/L, GGT 65 — that is iron overload pattern, and it deserves a hereditary hemochromatosis workup. Ferritin 320, TSAT 28 percent, hsCRP 4.2 mg/L, GGT 48 — that is metabolic inflammation pattern, and the answer is upstream: visceral fat, insulin resistance, and hepatic stress.
Same ferritin number. Two completely different clinical pictures. The standard physical doesn't order any of the supporting markers, so the number gets dismissed as "high-normal" and the underlying physiology stays invisible.
This is the educational frame, not a treatment recommendation. But the literature points to a small number of upstream levers that have been studied in the context of elevated ferritin and metabolic dysfunction:
Ferritin is one of a small handful of blood markers where the difference between "normal" and "optimal" matters more than almost any other number on the panel. It tracks two of the most consequential drivers of long-term disease — iron load and systemic inflammation — at a stage when neither has produced symptoms.
A man in his 40s with a ferritin of 300, no anemia, and a "clean" annual physical is, statistically, not a healthy man. He's a man whose physical never looked.
The blood work is already there. It just has to be ordered, run, and interpreted against a functional standard rather than a population average that has been pulled upward by the underlying disease the test is supposed to detect.
The Peptide Dispatch is an educational publication for clinicians, researchers, and informed patients. Content is for informational purposes only and does not constitute medical advice. Discuss any blood work, supplement, or treatment decisions with a qualified clinician familiar with your individual case.
Sources: 2023 Nature Reviews Endocrinology consensus statement on metabolic hyperferritinaemia; Diabetes Care NHANES analyses on ferritin and metabolic syndrome; Metallomics 2021 review on optimal serum ferritin ranges; published mortality data from the HEIRS Study cohort.
Educational content — not medical advice. Effects described are drawn from cited research in study subjects.